Teva Pharmaceutical Industries Limited (TEVA)
USD 21.2
(1.53%)
USD 21.2
(1.53%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 16.92 Billion USD | -9.77% |
| 2022 | 18.76 Billion USD | -11.9% |
| 2021 | 21.29 Billion USD | -12.08% |
| 2020 | 24.22 Billion USD | -4.52% |
| 2019 | 25.36 Billion USD | -6.51% |
| 2018 | 27.13 Billion USD | -13.89% |
| 2017 | 31.51 Billion USD | -9.48% |
| 2016 | 34.81 Billion USD | 1051.95% |
| 2015 | 3.02 Billion USD | -62.7% |
| 2014 | 8.1 Billion USD | -27.36% |
| 2013 | 11.15 Billion USD | -5.79% |
| 2012 | 11.83 Billion USD | -11.78% |
| 2011 | 13.42 Billion USD | 213.48% |
| 2010 | 4.28 Billion USD | -1.45% |
| 2009 | 4.34 Billion USD | -34.07% |
| 2008 | 6.58 Billion USD | 78.08% |
| 2007 | 3.7 Billion USD | -7.38% |
| 2006 | 3.99 Billion USD | 357.51% |
| 2005 | 873.2 Million USD | -32.29% |
| 2004 | 1.28 Billion USD | 220.58% |
| 2003 | 402.3 Million USD | -63.09% |
| 2002 | 1.09 Billion USD | 59.24% |
| 2001 | 684.48 Million USD | -6.85% |
| 2000 | 734.78 Million USD | 24.43% |
| 1999 | 590.5 Million USD | 23.25% |
| 1998 | 479.1 Million USD | 50.28% |
| 1997 | 318.8 Million USD | -27.73% |
| 1996 | 441.1 Million USD | 93.63% |
| 1995 | 227.8 Million USD | 28.92% |
| 1994 | 176.7 Million USD | 27.4% |
| 1993 | 138.7 Million USD | 15.68% |
| 1992 | 119.9 Million USD | 11.95% |
| 1991 | 107.1 Million USD | -1.38% |
| 1990 | 108.6 Million USD | 25.12% |
| 1989 | 86.8 Million USD | 41.83% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 16.94 Billion USD | 0.12% |
| 2024 Q2 | 16.66 Billion USD | -1.67% |
| 2023 Q1 | 18.89 Billion USD | 0.71% |
| 2023 Q3 | 18.04 Billion USD | -1.62% |
| 2023 Q2 | 18.34 Billion USD | -2.89% |
| 2023 Q4 | 16.92 Billion USD | -6.22% |
| 2023 FY | 16.92 Billion USD | -9.77% |
| 2022 Q4 | 18.76 Billion USD | -3.27% |
| 2022 Q1 | 21.13 Billion USD | -0.75% |
| 2022 Q2 | 20.39 Billion USD | -3.5% |
| 2022 FY | 18.76 Billion USD | -11.9% |
| 2022 Q3 | 19.39 Billion USD | -4.9% |
| 2021 Q2 | 23.14 Billion USD | -2.29% |
| 2021 Q1 | 23.68 Billion USD | -2.22% |
| 2021 Q4 | 21.29 Billion USD | -3.76% |
| 2021 Q3 | 22.12 Billion USD | -4.38% |
| 2021 FY | 21.29 Billion USD | -12.08% |
| 2020 Q2 | 24.27 Billion USD | -1.75% |
| 2020 Q3 | 24.26 Billion USD | -0.05% |
| 2020 Q1 | 24.71 Billion USD | -2.59% |
| 2020 Q4 | 24.22 Billion USD | -0.19% |
| 2020 FY | 24.22 Billion USD | -4.52% |
| 2019 Q4 | 25.36 Billion USD | -2.79% |
| 2019 Q2 | 26.98 Billion USD | -0.33% |
| 2019 FY | 25.36 Billion USD | -6.51% |
| 2019 Q1 | 27.07 Billion USD | -0.22% |
| 2019 Q3 | 26.09 Billion USD | -3.31% |
| 2018 Q2 | 28.37 Billion USD | -3.27% |
| 2018 Q1 | 29.33 Billion USD | -6.91% |
| 2018 FY | 27.13 Billion USD | -13.89% |
| 2018 Q4 | 27.13 Billion USD | -1.74% |
| 2018 Q3 | 27.61 Billion USD | -2.69% |
| 2017 Q1 | 33.73 Billion USD | -3.09% |
| 2017 Q3 | 34.02 Billion USD | -1.25% |
| 2017 FY | 31.51 Billion USD | -9.48% |
| 2017 Q2 | 34.45 Billion USD | 2.13% |
| 2017 Q4 | 31.51 Billion USD | -7.38% |
| 2016 Q1 | 4.23 Billion USD | 40.17% |
| 2016 FY | 34.81 Billion USD | 1051.95% |
| 2016 Q3 | 35.29 Billion USD | 797.25% |
| 2016 Q4 | 34.81 Billion USD | -1.38% |
| 2016 Q2 | 3.93 Billion USD | -7.13% |
| 2015 Q3 | 10.73 Billion USD | -6.24% |
| 2015 FY | 3.02 Billion USD | -62.7% |
| 2015 Q2 | 11.45 Billion USD | 50.24% |
| 2015 Q1 | 7.62 Billion USD | -5.93% |
| 2015 Q4 | 3.02 Billion USD | -71.85% |
| 2014 Q2 | 10.22 Billion USD | -6.19% |
| 2014 Q1 | 10.89 Billion USD | -2.31% |
| 2014 Q4 | 8.1 Billion USD | -11.72% |
| 2014 FY | 8.1 Billion USD | -27.36% |
| 2014 Q3 | 9.17 Billion USD | -10.21% |
| 2013 Q1 | 11.26 Billion USD | -4.86% |
| 2013 Q2 | 11.21 Billion USD | -0.44% |
| 2013 FY | 11.15 Billion USD | -5.79% |
| 2013 Q4 | 11.15 Billion USD | -2.59% |
| 2013 Q3 | 11.44 Billion USD | 2.1% |
| 2012 FY | 11.83 Billion USD | -11.78% |
| 2012 Q1 | 13.46 Billion USD | 0.3% |
| 2012 Q4 | 11.83 Billion USD | -4.2% |
| 2012 Q2 | 12.85 Billion USD | -4.48% |
| 2012 Q3 | 12.35 Billion USD | -3.88% |
| 2011 Q2 | 5.23 Billion USD | -13.16% |
| 2011 Q1 | 6.03 Billion USD | 7.1% |
| 2011 Q4 | 13.42 Billion USD | 89.17% |
| 2011 Q3 | 7.09 Billion USD | 35.41% |
| 2011 FY | 13.42 Billion USD | 213.48% |
| 2010 Q1 | 3.75 Billion USD | 3.84% |
| 2010 Q4 | 5.63 Billion USD | -9.34% |
| 2010 Q3 | 6.21 Billion USD | 187.24% |
| 2010 Q2 | 2.16 Billion USD | -42.41% |
| 2010 FY | 4.28 Billion USD | -1.45% |
| 2009 FY | 4.34 Billion USD | -34.07% |
| 2009 Q2 | 5.64 Billion USD | -15.92% |
| 2009 Q3 | 4.84 Billion USD | -14.02% |
| 2009 Q4 | 3.61 Billion USD | -25.41% |
| 2009 Q1 | 6.7 Billion USD | 1.81% |
| 2008 Q2 | 2.26 Billion USD | -21.07% |
| 2008 Q1 | 2.87 Billion USD | -22.41% |
| 2008 FY | 6.58 Billion USD | 78.08% |
| 2008 Q3 | 1.8 Billion USD | -20.3% |
| 2008 Q4 | 6.58 Billion USD | 264.84% |
| 2007 Q1 | 4.35 Billion USD | 8.91% |
| 2007 Q2 | 3.88 Billion USD | -10.66% |
| 2007 Q3 | 3.8 Billion USD | -2.19% |
| 2007 Q4 | 3.7 Billion USD | -2.68% |
| 2007 FY | 3.7 Billion USD | -7.38% |
| 2006 FY | 3.99 Billion USD | 357.51% |
| 2006 Q3 | 4.57 Billion USD | -4.27% |
| 2006 Q4 | 3.99 Billion USD | -12.66% |
| 2006 Q1 | 4.68 Billion USD | 437.07% |
| 2006 Q2 | 4.77 Billion USD | 1.89% |
| 2005 Q2 | 1.09 Billion USD | -16.42% |
| 2005 Q1 | 1.31 Billion USD | 1.92% |
| 2005 FY | 873.2 Million USD | -32.29% |
| 2005 Q4 | 873.2 Million USD | -27.25% |
| 2005 Q3 | 1.2 Billion USD | 9.25% |
| 2004 Q4 | 1.28 Billion USD | 2.61% |
| 2004 Q3 | 1.25 Billion USD | -31.92% |
| 2004 Q2 | 1.84 Billion USD | -2.72% |
| 2004 Q1 | 1.89 Billion USD | 371.74% |
| 2004 FY | 1.28 Billion USD | 220.58% |
| 2003 Q4 | 402.3 Million USD | -50.25% |
| 2003 Q3 | 808.7 Million USD | 12.23% |
| 2003 Q2 | 720.6 Million USD | -28.21% |
| 2003 Q1 | 1 Billion USD | -7.92% |
| 2003 FY | 402.3 Million USD | -63.09% |
| 2002 Q3 | 1.04 Billion USD | 22.72% |
| 2002 Q2 | 853.4 Million USD | 13.2% |
| 2002 Q1 | 753.9 Million USD | 10.14% |
| 2002 FY | 1.09 Billion USD | 59.24% |
| 2002 Q4 | 1.09 Billion USD | 4.08% |
| 2001 Q4 | 684.48 Million USD | 4.69% |
| 2001 FY | 684.48 Million USD | -6.85% |
| 2001 Q1 | 672.85 Million USD | -8.43% |
| 2001 Q2 | 658.78 Million USD | -2.09% |
| 2001 Q3 | 653.8 Million USD | -0.76% |
| 2000 Q1 | 569.65 Million USD | -3.53% |
| 2000 FY | 734.78 Million USD | 24.43% |
| 2000 Q2 | 789.01 Million USD | 38.51% |
| 2000 Q4 | 734.78 Million USD | 0.0% |
| 2000 Q3 | - USD | -100.0% |
| 1999 Q2 | 433.8 Million USD | -3.73% |
| 1999 Q3 | 624.5 Million USD | 43.96% |
| 1999 Q4 | 590.5 Million USD | -5.44% |
| 1999 FY | 590.5 Million USD | 23.25% |
| 1999 Q1 | 450.6 Million USD | -5.95% |
| 1998 Q3 | 478.6 Million USD | 28.97% |
| 1998 Q2 | 371.1 Million USD | 36.69% |
| 1998 Q1 | 271.5 Million USD | -14.84% |
| 1998 Q4 | 479.1 Million USD | 0.1% |
| 1998 FY | 479.1 Million USD | 50.28% |
| 1997 Q4 | 318.8 Million USD | 0.0% |
| 1997 FY | 318.8 Million USD | -27.73% |
| 1996 Q4 | 441.1 Million USD | 0.0% |
| 1996 FY | 441.1 Million USD | 93.63% |
| 1995 FY | 227.8 Million USD | 28.92% |
| 1995 Q4 | 227.8 Million USD | 0.0% |
| 1994 FY | 176.7 Million USD | 27.4% |
| 1994 Q4 | 176.7 Million USD | 0.0% |
| 1993 FY | 138.7 Million USD | 15.68% |
| 1993 Q4 | 138.7 Million USD | 0.0% |
| 1992 Q4 | 119.9 Million USD | 0.0% |
| 1992 FY | 119.9 Million USD | 11.95% |
| 1991 FY | 107.1 Million USD | -1.38% |
| 1991 Q4 | 107.1 Million USD | 0.0% |
| 1990 Q4 | 108.6 Million USD | 0.0% |
| 1990 FY | 108.6 Million USD | 25.12% |
| 1989 FY | 86.8 Million USD | 41.83% |
| 1989 Q4 | 86.8 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 2.65 Billion USD | -536.597% |
| Bausch Health Companies Inc. | 21.44 Billion USD | 21.053% |
| Catalent, Inc. | 4.69 Billion USD | -260.226% |
| Emergent BioSolutions Inc. | 765.8 Million USD | -2110.368% |
| Elanco Animal Health Incorporated | 5.42 Billion USD | -212.191% |
| Perrigo Company plc | 3.32 Billion USD | -409.527% |
| Zoetis Inc. | 4.76 Billion USD | -255.46% |